Background/Objectives: Leptin is present in human milk, but it is not clear what the relationship between breast milk (BM) leptin levels and maternal and infant serum leptin concentrations is. The objective of this study was to evaluate the leptin concentration in BM and to investigate its relationship with infants' and mothers' anthropometric parameters and with serum leptin concentration in breast-fed (BF) infants and lactating mothers. Subjects/Methods: We enrolled 36 adequate for gestational age healthy, exclusively BF, term infants aged o6 months. Leptin concentration in serum and BM was determined by radioimmunoassay (RIA) test (human-leptin-RIA-sensitive, Mediagnost). Infants' and mothers' weights, lengths and body mass indexes (BMI) were measured. Results: The median leptin concentration was 3.42 ng/ml (interquartile range (IR): 2.65) in BF infants' serum, 3.02 ng/ml (IR: 2.85) in mothers' serum (n ¼ 17) and 0.51 ng/ml (IR: 0.34) in BM (n ¼ 24). BM leptin concentrations were significantly lower than serum BF infant (Po0.001) and maternal (Po0.001) leptin levels. Infant serum leptin concentration correlated positively with infant weight (r ¼ 0.437, P ¼ 0.008) and BMI (r ¼ 0.561, P ¼ 0.004). Mother serum leptin levels correlated positively with weight (r ¼ 0.755, Po0.001) and BMI (r ¼ 0.661, P ¼ 0.007). No correlations were found between BM leptin and serum leptin concentrations in BF infants and mothers. Conclusions: We confirmed the presence of leptin in BM at a lower concentration than that found in infant and lactating mother serum. We observed a positive correlation between serum leptin levels in BF infants and their growth parameters.
Introduction
Human milk contains a wide variety of proteins that provide adequate nutrition to breast-fed (BF) infants and simultaneously help in the development of important physiological functions (Lönnerdal, 2003) . Many of these proteins sustain growth; some have a role in the digestion and utilization of nutrients; some others show antimicrobial action or exert immunomodulatory activities or are growth factors involved in gut maturation of newborns (Wagner et al., 2008) . All these properties let human milk proteins to contribute to the unique qualities of breast milk (BM).
The importance of human milk in infant development has been recently underscored by a large and growing body of scientific literature showing that nutrition during infancy may be linked to metabolic health disorders in later life (Demmelmailr et al., 2006) . In particular, prolonged breast feeding seems to be associated with a lower risk of later obesity compared with formula feeding (Singhal and Lanigan, 2007) . Since the identification of leptin in BM, this hormone has been proposed to be responsible for some of the beneficial effects of breast feeding and to be involved in early-life programming of obesity (Stocker and Cawthorne, 2008) .
Leptin is a 167-amino-acid peptide primarily expressed in adipose tissue (Zhang et al., 1994) , but also produced by the stomach (Cinti et al., 2001) , placenta (Masuzaki et al., 1997) and mammary epithelial cells (Smith-Kirwin et al., 1998) , and it has been found in the cord blood of newborns (Shekhawat et al., 1998) . Leptin exerts pleiotropic effects by binding and activating specific receptors, in particular in the arcuate nucleus in the hypothalamus, where it contributes to the control of energy homeostasis, by reducing food intake and increasing energy expenditure (Faroooqi and O'Rahilly, 2009) . Leptin is involved in the regulation of several physiological processes, including inflammation, angiogenesis, hematopoiesis, immune function and reproduction, and has a role in modulating glucose and fat metabolism by improving insulin sensitivity and reducing intracellular lipids (Huang and Li, 2000) . Circulating leptin levels are positively correlated with the amount of body fat (Chan and Mantzoros, 2005) .
Leptin circulates in plasma as a free form or bound to leptin-binding proteins, and interacts directly with the leptin receptor (Ob-R), which is a cytokine receptor and isencoded by the db gene (Lammert et al., 2001) .
Leptin has a role in the perinatal development of those areas of the hypothalamus that are involved in the central regulation of energy balance: it promotes the formation of neural circuits controlling food intake and adiposity later in life, acting on the brain during a restricted neonatal critical period. It has been observed that a postnatal surge in plasma leptin might serve as a key developmental signal (Bouret and Simerly, 2006) . Some studies in literature suggest a relationship between leptin levels in BM and serum leptin concentration in lactating mothers, probably because of the ability of leptin to be transferred from serum to BM (Houseknecht et al., 1997; Weyermann et al., 2006) , and we recently observed a higher leptin concentration in BF infants than in artificially fed ones (Savino et al., 2005 (Savino et al., , 2006 .
Recent data about leptin concentration in BM showed variations mainly according to the BM fractions and the sample treatments used ( Table 1) .
The aim of this study was to evaluate leptin concentrations in BM and its relationship with serum leptin concentration in BF infants and lactating mothers, and with infants' and mothers' anthropometric parameters.
Materials and methods

Study population
We enrolled in a cross-sectional study 36 healthy term infants admitted in the Department of Paediatrics of the University of Turin, Regina Margherita Children's Hospital. Inclusion criteria were age o6 months, gestational age between 37 and 42 weeks, birth weight between 2500 and 4000 g, Apgar score 47 at 5 min, exclusively breast feeding. Exclusion criteria were neonatal disease, fever, chronic illness, current pathology compromising growth and partial breast feeding.
Infants were weighed naked before feeding (electronic integrating scale, SECA, model 757, Vogel & Halke, Hamburg, Germany), crown-to-heel length was measured (Harpenden stadiometer, Holtain Ltd, Crosswell, Crymych, Pembs., UK) and body mass index (BMI) was calculated (ratio between body weight (kg) and the square of length (m 2 )).
Milk samples and blood assays
Human milk samples were collected from lactating mothers who consented to participate in the study. Milk was collected by either hand expression or a hand-held electric pump and was frozen at À20 1C until analysis. Samples were thawed at room temperature and vortexed continuously during pipetting to ensure sample uniformity. Skim milk was prepared by centrifugation of whole milk at 2000 g for 20 min at 4 1C, after which the fat layer was removed.
Venous blood samples from infants and lactating mothers were collected at 0800 hours with a fasting time of 3 h and were treated with a cooled (4 1C) centrifuge at 4000 r.p.m. for 10 min; serum was stored at À20 1C until analysis. Leptin in breast milk, infants and mothers F Savino et al
Immunoreactive leptin was measured both in blood and in milk using a commercially available radioimmunoassay (RIA) kit (LEP R-40, Human-Leptin-RIA-Sensitive, Mediagnost, Reutlingen, Germany). Leptin's intra-assay variation was o5% and inter-assay variation was o7.6% and its sensitivity was 0.04 ng/ml.
The study protocol was approved by the local ethics committee and infants' parents gave their written consent.
Statistical analysis
Statistical analyses were performed with SPSS (release 12.0, SPSS Inc., Chicago, IL, USA). Leptin data are shown as median and interquartile range (IR). Infants' and mothers' anthropometric data are shown as mean±s.d. BM leptin concentrations and infants' serum leptin concentrations were logarithmically transformed to normalize the distribution (ln, natural logarithm). We used the Wilcoxon test to compare the median concentration of leptin in mothers' serum with infants' serum leptin and BM leptin, while the t-test was applied to compare infants' serum leptin and BM leptin concentrations. Spearman's or Pearson's correlations were applied. A P value o0.05 was considered statistically significant.
Results
The median leptin concentration in BM (n ¼ 24) was 0.51 ng/ml (IR: 0.34), in BF infants (n ¼ 36) was 3.42 ng/ml (IR: 2.65) and in mothers was 3.02 ng/ml (IR: 2.85). On comparing BM leptin levels with serum leptin concentrations in infants and mothers, we observed that BM leptin levels were significantly lower than both serum BF infant (Po0.001) and maternal (Po0.001) leptin levels (Figures 1-3) .
Infants' and mothers' anthropometric characteristics are shown in Table 2 . Infant serum leptin concentration correlated positively with infant weight (r ¼ 0.437, P ¼ 0.008) and BMI (r ¼ 0.561, P ¼ 0.004). Mother serum leptin levels correlated positively with mother weight (r ¼ 0.755, Po0.001) and BMI (r ¼ 0.661, P ¼ 0.007). The correlation between BM leptin levels and serum leptin concentration in BF infants and mothers was not statistically significant. No correlations emerged between infants' and mothers' BMI and body weight.
Discussion
The presence of leptin in BM raised questions regarding the ability of the mammary epithelial cells to transfer leptin from the blood or to synthesize it before its secretion. Casabiell et al. (1997) , in their experimental studies on neonatal rats, showed that leptin is transferred from the maternal circulation to BM and that leptin present in maternal milk ingested during the suckling period can Leptin in breast milk, infants and mothers F Savino et al be absorbed by the immature gastric mucosa and can be transferred to rat circulation. Leptin receptors have been identified in gastric epithelial cells and in the absorptive cells of mouse and human small intestine, which suggests that leptin could pass from milk to infant blood (Barrenetxe et al., 2002) . Smith-Kirwin et al. (1998) showed that leptin gene is expressed in the mammary gland of lactating women and that leptin is produced by mammary epithelial cells. Studies in animals by applying the quantitative analysis of leptin mRNA level, using RT-PCR, showed that leptin gene expression is regulated during gestation and lactation stages. In addition, the cellular location of the leptin protein studied by immunohistochemical analysis was shown to be dependent on the gestation or lactation stages: leptin protein was detected in mammary adipocytes during the early stages of pregnancy, in epithelial cells and mainly on their apical membrane just before parturition, and in myoepithelial cells during lactation (Bonnet et al., 2002) .
In the present work, we confirmed the presence of leptin in BM at similar concentrations to those found in previous studies wherein leptin was evaluated in the sample of breast skim milk using RIA (Table 1) .
We chose to evaluate leptin in skim milk considering evidence in literature showing that leptin concentrations of whole milk were higher than those of skim milk and that fat in human milk interfered with the leptin assay. In a work performed by Houseknecht et al. (1997) , leptin was found to be at a 10-fold higher concentration in sonicated whole milk as compared with skimmed samples of human milk, because a portion of leptin seemed to be associated with the milk fat droplet or fat-associated proteins. Smith-Kirwin et al. (1998) observed immunoreactive leptin in whole BM at 30-to 150-fold higher concentrations than skim milk, suggesting that leptin is linked to the fat globules in BM. Furthermore, Lonnerdal and Havel (2000) evaluated leptin concentrations in samples of whole and skim human milk obtained from healthy women in mid-lactation (2-4 months) using RIA. They observed that lipids have to be removed because of their interference with the leptin assay.
Further, in our work we observed that leptin concentration in BM was lower than that found in infant and lactating mother serum. This finding is in accordance with the data reported by other authors. In fact, Casabiell et al. (1997) observed that leptin levels in human milk were lower than those in the serum of lactating mothers. Houseknecht et al. (1997) quantified leptin concentration in human milk in the range of concentrations found in human plasma. Uçar et al. (2000) also observed lower levels in BM than in maternal plasma, and from a study by Lonnerdal and Havel (2000) it emerged that BM leptin values were B10-fold lower than the serum leptin concentrations in infants. Weyermann et al. (2006) , who measured leptin in BM using ELISA, observed that leptin concentration in BM was B70-fold lower than that in maternal serum.
In the present work, we observed positive correlations between serum leptin levels in BF infants and their growth parameters, and between serum leptin levels in lactating mothers and their own anthropometric parameters. Regarding this topic, Houseknecht et al. (1997) observed that leptin concentrations in human milk were correlated with maternal plasma leptin concentrations, maternal body weight, BMI and skinfold thickness. Weyermann et al. (2006) observed that leptin concentration in BM correlated positively with leptin in maternal serum. In addition, Bronsky et al. (2006) evaluated BM leptin concentration, but they applied the ELISA method. They found positive correlations between BM leptin concentrations and body weight and between the BMI of mothers before pregnancy and at the time of delivery; leptin in BM also correlated with body weight gain during pregnancy. Bronsky et al. (2006) found lower leptin concentrations in the BM of mothers who delivered preterm babies than in those who delivered at-term babies. Uysal et al. (2002) , using RIA, observed no significant difference in BM leptin concentrations between the mothers of obese and non-obese infants; BM leptin concentrations correlated with mother's BMI.
In contrast to the other works present in literature, we did not observe significant correlations between BM leptin levels and leptin concentration in the serum of infants and lactating mothers.
Lastly, we have to take into account the recent findings of Palou and Pico (2009) in animal models, which report that direct cause-effect evidence was obtained in rats, in which oral leptin supplementation during the suckling period resulted in a decrease in food intake, affected the food preferences in favor of carbohydrates versus fat and protected against overweight in adulthood, with an improvement in related parameters such as leptin and insulin sensitivity.
Further, in a study conducted by Picó et al. (2007) , it has been shown that oral leptin is absorbed by the immature gastric epithelium of the neonate and this leptin exerts clear biological effects in the earlier stages of neonatal life, downregulating endogenous leptin production, and having a potential role in the short-term control on food intake during this period.
The results obtained in humans showing a negative association between BM leptin concentration and body weight gain in infants (Miralles et al., 2006) , together with the direct cause-effect evidence obtained in rats (Picó et al., 2007;  Leptin in breast milk, infants and mothers F Savino et al Sánchez et al., 2008) , identify a new role for leptin as an essential element during lactation.
In the present work, we confirmed the presence of leptin in BM at a lower concentration than that found in infant and lactating mother serum. We observed a positive correlation between serum leptin levels in BF infants and their growth parameters, but not with leptin concentrations in mothers' serum and BM.
In conclusion, epidemiological data and experimental models show that fetal and early postnatal nutrition are key determinants in influencing infant growth; although the precise molecular mechanisms underlying this relationship are unclear, it is evident that there are critical time windows when these effects are important. The role of breast feeding in the protection against the development of chronic diseases later in life, in particular obesity, has been supported by epidemiological studies (Bartok and Ventura, 2009; Palou and Pico, 2009) ; however, the identification of hormones involved in food intake and energy balance regulation in BM, in particular leptin (Savino et al., 2009) , open a new area of research.
As modification of infant feeding practice has an important potential role for long-term health promotion and should prompt a review of the recommendations and policies for infant formula composition (Agostoni et al., 2009; Koletzko et al., 2009) , an increased understanding of early infant's nutrition and metabolism can open up new perspectives for related interventions to promote breast feeding.
